share_log

聖諾醫藥-B:自願性公告 - Sirnaomics宣佈完成針對靶向APOC3用於治療心血管疾病的STP125G在非人靈長類動物模型中安全性和有效性的IND準備階段研究

SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - SIRNAOMICS ANNOUNCES COMPLETION OF IND-ENABLINGSTUDIES OF SAFETY AND EFFICACY FOR STP125G WITHNHP MODELS, TARGETING APOC3 FOR TREATMENT OFCARDIOVASCULAR DISEASES

Hong Kong Stock Exchange ·  Jul 12 12:02

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.